4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
March 12, 2010 03:06 pm US/Eastern
Search
Dynamic quotes   
On
 | Off

4-Traders Homepage  >  Shares  >  NYSE  >  WATSON PHARM   WPI   US9426831031

Real time Streaming quotes -

WATSON PHARM (WPI)

  
Delayed Quote. Delayed NYSE - 03/12 02:51:27 pm
41.02 USD   +0.10%
03/11WATSON PHARM: FDA Approves Watson's TRELSTAR(R) 22.5 mg, the Fir..
03/10WATSON PHARM: Watson Announces Actos(R) Patent Challenge Settlem..
03/08WATSON PHARM: Watson Confirms Filing of Generic Opana(R) ER Appl..
SummaryQuotesChart AnalysisNewsFundamentalsConsensus
 NewsRSS News
Latest news on WATSON PHARM
03/11FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month ..
03/10Watson Announces Actos(R) Patent Challenge Settlement
03/08Watson Confirms Filing of Generic Opana(R) ER Application
03/04Watson Announces Agreement to Acquire U.S. Rights to Columbia Laborato..
03/01Watson Signs Agreement to Divest Equity Interest in ScinoPharm
03/01Watson Licenses Population Council's Novel Contraceptive Ring
02/26Watson to Present at CLSA/Asia USA Investor's Forum
02/23Watson Reports Net Revenue of $786 Million for the Fourth Quarter 2009
02/22Watson Files FDA Application for Generic Aplenzin(TM) ER
02/02Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2..
02/01Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commer..
01/28Watson Completes Acquisition of Eden Biodesign
01/21Watson Provides Overview of Global Operations; Delivers Outlook for Co..
01/19/C O R R E C T I O N -- Watson Pharmaceuticals, Inc./
01/13Watson Announces Preliminary Financial Performance for FY 2009
01/08Watson Files FDA Application for Generic LoSeasonique(R)
01/06Watson Files FDA Application for Generic Nuvigil(R)
01/06Watson to Present at 28th Annual JPMorgan Healthcare Conference
2009Watson Announces New Program to Help Promote Good Bone Health in Advan..
2009New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerabi..
2009Watson Files FDA Application for Generic Rozerem(R)
2009Watson Completes Acquisition of Arrow Group
2009Watson Completes Acquisition of Arrow Group
2009Watson Receives FTC Clearance for Arrow Acquisition
2009Watson Names Robert A. Stewart Senior Vice President, Global Operation..
2009Watson Announces Presentation Time Change at Credit Suisse Healthcare ..
2009Watson to Present at Credit Suisse Healthcare Conference
2009Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $..
2009Watson Names R. Todd Joyce Senior Vice President and Chief Financial O..
2009Watson and Barr Settle Lawsuit Over Oxytrol(R)
2009New Data Suggest that GELNIQUE(R) (oxybutynin chloride) gel 10% Does N..
2009Watson Names G. Frederick Wilkinson Executive Vice President, Global B..
2009Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for..
2009Watson Prices $850 Million of Senior Unsecured Notes
2009Watson Announces Offering of Senior Unsecured Notes
2009Watson Announces Limited Recall Of Fentanyl Transdermal System
2009Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
2009Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) ..
2009Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; ..
2009Watson Announces License Agreement With GeneraMedix for Generic Versio..
2009Watson CFO Mark W. Durand to Take Leave of Absence
2009Watson Confirms Filing of Abbreviated New Drug Application for Generic..
2009Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-..
2009Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Inje..
2009Watson to Host Second Quarter 2009 Earnings Conference Call and Webcas..
2009Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Fl..
2009Watson Wyatt shares slide, deal concerns cited
2009Towers Perrin, Watson Wyatt to merge in $3.5 billion deal
2009Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Dire..
2009U.S. consultants Towers Perrin, Watson Wyatt to merge
1  2  3Next
Chart WATSON PHARM
Short term
Mid-term
Long term
Graphique historique des cours de bourse de WATSON PHARM
>> Full-screen chart
Price share WATSON PHARM (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /